Affinity Asset Advisors, LLC Cure Vac N.V. Transaction History
Affinity Asset Advisors, LLC
- $560 Million
- Q4 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 50,000 shares of CVAC stock, worth $165,000. This represents 0.62% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$165,000% of portfolio
0.62%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CVAC
# of Institutions
86Shares Held
10.5MCall Options Held
75.5KPut Options Held
33.5K-
Black Rock Inc. New York, NY2.25MShares$7.44 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$5.44 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.18 Million10.6% of portfolio
-
Ubs Group Ag577KShares$1.9 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$1.65 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $619M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...